DSM Venturing

DSM Venturing is the corporate venture capital arm of Royal DSM, established in 2001 and headquartered in Heerlen, Netherlands. The firm focuses on investing in start-up companies that develop innovative products and services within the life sciences sector, which encompasses both animal and human health and nutrition. Over the years, DSM Venturing has invested in more than fifty emerging companies across the United States, Europe, and Israel. Its primary objective is to generate strategic options and enhance value for DSM and its broader ecosystem while achieving sustainable venture-grade investment returns.

Rob Beudeker

Investment Director

Scott Horner

Regional Managing Director North America

Marcel Kloosterman

Investment Manager

Greg McParland

Investment Director

Erik Rutten

Senior Investment Manager

Past deals in Dietary Supplements

Vivici

Series A in 2025
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.

NutriLeads

Series C in 2023
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Vivici

Seed Round in 2023
Vivici is a B2B company specializing in the production and supply of animal-free dairy proteins. Utilizing precision fermentation technology, they create nutritious and sustainable ingredients for food and beverage manufacturers, aiming to meet the increasing global demand for functional and environmentally friendly protein sources.

VitaminLab

Series A in 2023
VitaminLab is a biopharmaceutical company focused on providing personalized vitamins tailored to individual health needs. Utilizing a matching algorithm, the company combines health history, nutrient testing, and health data to create customized supplements. Founded by a team of pharmacists and healthcare professionals, VitaminLab aims to transform the supplement industry by offering products made from all-natural ingredients, including beetroot, stevia, and prebiotics. By considering factors such as DNA, blood composition, and body type, VitaminLab delivers a unique approach to supplement formulation that prioritizes individual health and wellness.

Flore by Sun Genomics

Series B in 2022
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Momentous

Series A in 2022
Momentous is a nutritional supplement company based in Palo Alto, California, founded in 2016 by Matt Wan and Rob Dyrdek. The company specializes in performance products tailored for athletes, utilizing insights from experts in professional sports leagues such as the NFL, NBA, and NHL. Momentous emphasizes the use of high-quality, organic, and gluten-free ingredients in its formulations, ensuring that its supplements are clean, safe, and effective. The product line is designed to enhance athletic performance while providing exceptional taste without the use of fillers.

OK Capsule

Seed Round in 2022
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

OK Capsule

Seed Round in 2021
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

Prenexus Health

Series B in 2021
Prenexus Health, Inc. is a company that specializes in the research, development, and production of natural prebiotic ingredients designed for functional foods, beverages, and dietary supplements. Founded in 2015 and based in Gilbert, Arizona, Prenexus Health focuses on digestive health and wellness through its innovative prebiotic offerings, such as XOS95, a highly purified ingredient derived from high-fiber sugarcane. The company's commitment to scientific and clinical research positions it as a leader in the prebiotic market, providing clients in the fast-moving consumer goods sector with effective ingredients that enhance the health benefits of their products.

Brains Bioceutical

Series A in 2021
Brains Bioceutical Corp. is a Vancouver-based company that specializes in the production of naturally-sourced active pharmaceutical ingredients (APIs) for the pharmaceutical and nutraceutical industries. The company offers a range of products, including CBD oil, capsules, balms, and sprays, which are designed to serve various sectors such as health and wellness, skin and beauty, and veterinary care. Brains Bioceutical follows Good Manufacturing Practices (GMP) and emphasizes the use of high-quality, plant-based ingredients that are tetrahydrocannabinol-free, non-genetically modified, and vegan. This commitment allows the company to provide accessible and affordable products that meet the needs of patients seeking reliable wellness solutions.

Frontier Nutrition

Series B in 2021
Frontier Nutrition, Inc. is a company that develops and manufactures fortified packaged food products aimed at addressing the nutritional needs of low and middle-income families in underserved communities worldwide. Founded in 2017 by Eddie Bearnot and Tanveer Ali, the company is headquartered in New Haven, Connecticut. Frontier Nutrition's offerings are informed by research in pediatric nutrition and behavioral marketing, ensuring that recipes are tailored to local diets while being optimized for taste, nutrition, and affordability. The company's mission is to combat early life and maternal malnutrition by providing low-cost, convenient food options to families facing challenges such as limited access to healthcare, transportation, and clean water, thereby promoting a sustainable standard of living.

NutriLeads

Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

ZeaVision

Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.

NutriLeads

Series A in 2017
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Blue Prairie

Series A in 2016
Blue Prairie Brands LLC, based in Charlottesville, Virginia, specializes in the manufacture of inulin, a prebiotic ingredient known for its health benefits. The company produces soluble, indigestible fibers that enhance the nutritional content of various food products, beverages, and dietary supplements. Their flagship product is a gluten-free, non-GMO form of inulin, which supports digestive health when combined with probiotics. Additionally, Blue Prairie's innovative approach to production offers farmers a profitable rotation crop that aligns with their existing agricultural practices. By focusing on functional foods and dietary fiber, Blue Prairie Brands aims to improve the nutritional value of products in the market while promoting a healthy gut environment.

NutriLeads

Seed Round in 2015
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Natreon

Venture Round in 2015
Natreon, Inc. specializes in the development and marketing of Ayurvedic products, focusing on dietary supplements derived from traditional herbal ingredients. The company's product lineup includes CAPROS, an all-natural antioxidant for cardiovascular health; SENSORIL, an Ashwagandha extract that promotes stress relief and cognitive function; AYUFLEX, aimed at supporting joint health; and PRIMAVIE, a mitochondrial energy booster. Natreon emphasizes extensive research and development, ensuring high standards of product quality through multiple clinical and safety studies. The company holds patents for its offerings both in the United States and internationally. Headquartered in New Brunswick, New Jersey, Natreon operates a state-of-the-art research facility in Kolkata, India, to enhance its innovative capabilities in Ayurvedic medicine.

EyePromise

Venture Round in 2014
EyePromise is a manufacturer of dietary supplements focused on promoting ocular health and combating age-related vision loss. The company specializes in zeaxanthin supplements, which are designed for individuals at risk of developing age-related macular degeneration. EyePromise offers a range of products, including the EyePromise restore supplement, targeted for professional use, and EyePromise ten, which caters to consumers seeking zeaxanthin. Additionally, EyePromise provides the QuantifEYE program, a tool for assessing the risk of vision deterioration. Through its offerings, EyePromise aims to enhance visual performance, alleviate dry eyes, and support overall vision health.

ChromaDex

Post in 2013
ChromaDex Corporation is a global nutraceutical company based in Los Angeles, California, focused on promoting healthy aging through innovative ingredient technologies. The company is best known for its flagship product, Nicotinamide riboside (NIAGEN), a patented form of vitamin B3 that enhances nicotinamide adenine dinucleotide (NAD+) levels, which naturally decline with age. In addition to NIAGEN, ChromaDex offers Immulina, a spirulina extract designed to improve immune function. The company operates through three main segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the majority of its revenue generated from the Consumer Products segment. ChromaDex markets its products directly in the United States and Canada, while also utilizing international distributors, and employs in-house expertise in chemistry, regulatory affairs, and safety consulting to develop commercially viable ingredients across various industries, including dietary supplements, food, beverage, skin care, and pharmaceuticals.

Ganeden Biotech

Venture Round in 2007
Ganeden, Inc. is a manufacturer and supplier of probiotics and probiotic bacteria, focusing on the development of superior strains through a proprietary fermentation process. The company licenses its probiotic technology for various applications, including functional foods and beverages, dietary supplements, and topical products. Notable offerings include GanedenBacillus coagulans for food and companion animal use, Bonicel for personal care products aimed at anti-aging, and Staimune for immune health. Established in 1997 and headquartered in Mayfield Heights, Ohio, Ganeden has launched successful consumer lines such as Digestive Advantage and Sustenex, selling nearly 200 million doses across over 40,000 retail outlets. The company also maintains a strategic alliance with Sensus America. As of October 2017, Ganeden operates as a subsidiary of Kerry Group plc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.